Patents Assigned to Hemcon Medical Technologies (IP) Limited
  • Patent number: 8865680
    Abstract: A surgical gel system for coating and adhering to a wound area to control bleeding while supporting wound healing comprises polyanhydroglucuronic acid or a biocompatible salt in an amount of from 1% to 15% by weight and pectin in an amount of in an amount of from 0.1% to 9% by weight. The gel system may be used for stopping bleeding during or after sinus surgery, for stopping bleeding in ear nose and throat procedures, for stopping bleeding in gynecological procedures, or for stopping bleeding in internal organ procedures.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: October 21, 2014
    Assignee: Hemcon Medical Technologies (IP) Limited
    Inventors: Radim Dvorak, Radka Bartosovska, Jitka Vankova, Sam Kuhn, Keith Real, Jennifer M. Genco, Jennifer Adams
  • Publication number: 20130165402
    Abstract: A surgical gel system for coating and adhering to a wound area to control bleeding whilst supporting wound healing comprises polyanhydroglucuronic acid or a biocompatible salt in an amount of from 1% to 15% by weight and pectin in an amount of in an amount of from 0.1% to 9% by weight. The gel system may be used for stopping bleeding during or after sinus surgery, for stopping bleeding in ear nose and throat procedures, for stopping bleeding in gynecological procedures, or for stopping bleeding in internal organ procedures.
    Type: Application
    Filed: November 30, 2012
    Publication date: June 27, 2013
    Applicant: HEMCON MEDICAL TECHNOLOGIES (IP) LIMITED
    Inventor: HEMCON MEDICAL TECHNOLOGIES (IP) LIMITE
  • Publication number: 20130110025
    Abstract: A wound dressing device for use with a transcutaneous medical device such as a cannula or a catheter comprises a polyurethane matrix which may be covered with a film backing. Chlorhexidine di- gluconate and a polyanhydroglucuronic salt are contained in the polymer matrix. The wound dressing device prevents microbial colonization of the dressing and stops bleeding from the insertion site. The device provides combined haemostatic and antimicrobial effects at the insertion site but without adversely affecting wound healing.
    Type: Application
    Filed: July 4, 2011
    Publication date: May 2, 2013
    Applicant: Hemcon Medical Technologies (IP) Limited
    Inventors: Peter Donnellan, Marie Ni Beiliu, Keith Real